Edition:
India

Revance Therapeutics Inc (RVNC.OQ)

RVNC.OQ on NASDAQ Stock Exchange Global Market

25.95USD
17 Nov 2017
Change (% chg)

$0.45 (+1.76%)
Prev Close
$25.50
Open
$26.10
Day's High
$26.80
Day's Low
$25.80
Volume
103,414
Avg. Vol
40,749
52-wk High
$28.65
52-wk Low
$15.95

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.08 -0.903
Mar '17 0.08 -0.943
FY 2016 Dec '16 0.08 -0.950
Sep '16 0.08 -0.638
Jun '16 0.08 -0.876
Mar '16 0.08 -0.701
FY 2015 Dec '15 0.08 -0.835
Sep '15 0.08 -0.806
Jun '15 0.08 -0.713
Mar '15 0.08 -0.654
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 5 0.05 0.10 0.00 0.10
Quarter Ending Mar-18 1 0.10 0.10 0.10 0.10
Year Ending Dec-17 6 0.22 0.40 0.00 0.28
Year Ending Dec-18 6 0.22 0.60 0.00 0.35
Earnings (per share)
Quarter Ending Dec-17 5 -0.96 -0.90 -1.02 -0.89
Quarter Ending Mar-18 2 -0.71 -0.71 -0.72 -0.78
Year Ending Dec-17 5 -3.71 -3.25 -3.88 -3.08
Year Ending Dec-18 7 -3.46 -2.85 -4.24 -2.89
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 0.00 -21.37 -11.64
EPS (TTM) % -5.19 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Revance Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 147
Total Shares Held: 31,248,532
3 Mo. Net Change: -112,900
# New Positions: 13
# Closed Positions: 14
# Increased Positions: 53
# Reduced Positions: 58
# Net Buyers: -5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.